Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Jenner

Showing results (431-440 of 548) with videos related to

Pageof 55
Sort By:
Neuroscience Letters|January 7, 2000
Chronic L-DOPA treatment increases striatal cannabinoid CB1 receptor mRNA expression in 6-hydroxydopamine-lesioned ratsB Y Zeng, B Dass, A Owen, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 1, 1996
Reversal of behavioural abnormalities by fetal allografts in a novel rat model of striatonigral degenerationG K Wenning, R Granata, P M Laboyrie, et al.
Neuroscience Letters|September 7, 1984
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the common marmosetP Jenner, N M Rupniak, S Rose, et al.
Psychopharmacology|January 1, 1991
Motor activity following the administration of selective D-1 and D-2 dopaminergic drugs to normal common marmosetsP A Löschmann, L A Smith, K W Lange, et al.
Journal of Neurochemistry|September 1, 1989
A selective increase in particulate superoxide dismutase activity in parkinsonian substantia nigraH Saggu, J Cooksey, D Dexter, et al.
Plant Molecular Biology|May 14, 2024
Characterisation of the Arabidopsis thaliana telomerase TERT-TR complexBarbora Štefanovie, Leon P Jenner, Lucie Bozděchová, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 1, 1988
Leukocyte glutamate dehydrogenase activity in patients with degenerative neurological disordersD Aubby, H K Saggu, P Jenner, et al.
Lancet (London, England)|September 13, 1986
Lipid peroxidation as cause of nigral cell death in Parkinson's diseaseD Dexter, C Carter, F Agid, et al.
European Neurology|January 1, 1987
Single-dose studies of a slow-release preparation of levodopa and benserazide (Madopar HBS) in Parkinson's diseaseM H Marion, F Stocchi, S L Malcolm, et al.
Lancet (London, England)|June 3, 1989
Mitochondrial complex I deficiency in Parkinson's diseaseA H Schapira, J M Cooper, D Dexter, et al.
Pageof 55

Showing results (431-440 of 548) with videos related to

Sort By:
Pageof 55
Neuroscience Letters|January 7, 2000
Chronic L-DOPA treatment increases striatal cannabinoid CB1 receptor mRNA expression in 6-hydroxydopamine-lesioned ratsB Y Zeng, B Dass, A Owen, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 1, 1996
Reversal of behavioural abnormalities by fetal allografts in a novel rat model of striatonigral degenerationG K Wenning, R Granata, P M Laboyrie, et al.
Neuroscience Letters|September 7, 1984
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the common marmosetP Jenner, N M Rupniak, S Rose, et al.
Psychopharmacology|January 1, 1991
Motor activity following the administration of selective D-1 and D-2 dopaminergic drugs to normal common marmosetsP A Löschmann, L A Smith, K W Lange, et al.
Journal of Neurochemistry|September 1, 1989
A selective increase in particulate superoxide dismutase activity in parkinsonian substantia nigraH Saggu, J Cooksey, D Dexter, et al.
Plant Molecular Biology|May 14, 2024
Characterisation of the Arabidopsis thaliana telomerase TERT-TR complexBarbora Štefanovie, Leon P Jenner, Lucie Bozděchová, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 1, 1988
Leukocyte glutamate dehydrogenase activity in patients with degenerative neurological disordersD Aubby, H K Saggu, P Jenner, et al.
Lancet (London, England)|September 13, 1986
Lipid peroxidation as cause of nigral cell death in Parkinson's diseaseD Dexter, C Carter, F Agid, et al.
European Neurology|January 1, 1987
Single-dose studies of a slow-release preparation of levodopa and benserazide (Madopar HBS) in Parkinson's diseaseM H Marion, F Stocchi, S L Malcolm, et al.
Lancet (London, England)|June 3, 1989
Mitochondrial complex I deficiency in Parkinson's diseaseA H Schapira, J M Cooper, D Dexter, et al.
Pageof 55